Sabuwar Gwajin Lafiya na Ciwon Celiac

Sakin Kyauta | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

Immunic, Inc. a yau ya sanar da farawar ƙungiyoyin masu haƙuri a cikin ci gaba da gwajin gwaji na 1 na IMU-856, kashi na uku na asibiti na kamfanin, a cikin marasa lafiya da cutar celiac.

IMU-856 wani abu ne na baka kuma yana aiki akan tsari na ƙarami na ƙirar ƙwayoyin cuta wanda ke yin hari ga mai sarrafa epigenetic wanda ba a bayyana ba. Bincike na farko ya nuna cewa IMU-856 na iya dawo da aikin shinge a cikin gastrointestinal tract kuma ya sake farfado da gine-ginen hanji yayin da yake ci gaba da rashin ƙarfi. Dangane da ainihin bayanan asibiti da farkon bayanan da ake samu har zuwa yau, kamfanin ya yi imanin cewa IMU-856 na iya wakiltar wani sabon labari da yuwuwar hanyar warwarewa don magance cututtukan ciki.

"Farkon Sashe na C na wannan gwaji na gwaji na 1 a cikin marasa lafiya na celiac yana nuna muhimmiyar mahimmanci a cikin ci gaban asibiti na IMU-856, kuma muna fatan za mu iya tabbatar da ikonsa na mayar da aikin shinge na hanji ba tare da tasiri ga tsarin rigakafi ba," In ji Daniel Vitt, Ph.D., Babban Jami'in Gudanarwa kuma Shugaban Immunic. "Saboda yana wakiltar babban buƙatun da ba a biya ba tare da ingantattun alamun maye gurbi na ayyukan cutar, mun yi imanin cewa cutar Celiac ita ce kyakkyawar alamar asibiti ta farko don samar da hujja-na ra'ayi na IMU-856 ta m da na kullum tasiri. Tsarin IMU-856 na iya gabatar da sabuwar hanya gabaɗaya don magance adadi mai yawa na cututtukan gastrointestinal masu tsanani da yaɗuwa, kuma mun yi imanin zai iya ba da fa'idar asibiti ba tare da mummunan sakamakon da ke tattare da yawancin hanyoyin kwantar da hankali na autoimmune ba. Bugu da ƙari, muna sa ran samar da cikakkun bayanan aminci da aka saita daga ɓangaren kashi ɗaya da yawa masu tasowa na wannan gwajin gwaji na asibiti na 1 mai gudana a cikin batutuwan ɗan adam lafiya, a halin yanzu ana sa ran samun samuwa a cikin kwata na uku na wannan shekara. "

"Cutar Celiac cuta ce ta rayuwa mai tsayi kuma mai tsanani ta autoimmune na ƙananan hanji wanda ilimin pathophysiology ya kasance saboda lalacewar alkama da ke haifar da shingen hanji. Duk da bin abincin da ba shi da alkama, yawancin marasa lafiya suna fama da ayyukan cutar da ke gudana wanda zai iya haifar da zawo na yau da kullun, ciwon ciki, rashin abinci mai gina jiki har ma da haɗarin anemia, osteoporosis da wasu cututtukan daji, "in ji Andreas Muehler, MD, Babban Jami'in Lafiya. na rigakafi. "Akwai babbar buƙata don ingantaccen maganin warkewa ga marasa lafiya da cutar celiac, kamar yadda kawai hanyar warkewa a yau ita ce tsayayyen abinci marar yalwar abinci mai gina jiki, wanda ke da nauyi, sau da yawa yana hana jama'a, kuma ya kasa daina ayyukan cutar a kai a kai. . Dangane da yuwuwar IMU-856 don maido da aikin shinge na hanji da gine-ginen hanji, mun yi imanin wannan fili yana da alƙawarin musamman don haɓaka lafiyar gastrointestinal na marasa lafiya da ikon narkewa da kuma sha abubuwan gina jiki yadda yakamata, ta haka rage yiwuwar sakamako na dogon lokaci da haɓaka ingancin su. rayuwa, alamomin cututtuka da matsalolin da za a iya fuskanta a nan gaba."

Sassan A da B na ci gaba na gwaji na asibiti na lokaci 1 suna kimanta nau'ikan hawan hawan IMU-856 guda ɗaya da yawa a cikin batutuwan ɗan adam lafiya. Sashe na C da aka fara yanzu an tsara shi azaman 28-day, makafi biyu, gwajin sarrafa wuribo wanda aka tsara don tantance aminci da haƙuri na IMU-856 a cikin marasa lafiya da cutar celiac a lokacin lokutan cin abinci mara amfani da ƙalubalen alkama. Kimanin majiyyata 42 ana shirin yin rajista cikin ƙungiyoyi biyu a jere tare da IMU-856 da aka ba su sau ɗaya a rana sama da kwanaki 28. Makasudin na biyu sun haɗa da pharmacokinetics da alamun cututtuka, gami da waɗanda ke kimanta gine-ginen ciki da kumburi. Kimanin shafuka 10 a Ostiraliya da New Zealand ana tsammanin shiga Sashe na C.

Har ila yau, kamfanin ya sake nanata jagorancin sa na farko cewa lokaci na 2 babban layi na vidofludimus calcium (IMU 838) a cikin ulcerative colitis ana sa ran samuwa a watan Yuni na 2022 da kuma cewa farkon ingantaccen bayanan asibiti na Sashe na C na ci gaba na 1 na asibiti. Ana sa ran gwajin IMU-935 a cikin psoriasis a cikin rabin na biyu na 2022.

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...